D.A. Davidson & Co. Agilent Technologies, Inc. Transaction History

D.A. Davidson & Co.

$13.8 Billion
Q2 2025

A detailed history of D.A. Davidson & Co. transactions in Agilent Technologies, Inc. stock. As of the latest transaction made, D.A. Davidson & Co. holds 4,532 shares of A stock, worth $513,158. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,532

Previous 9,474 52.16%

Holding current value

$513,158

Previous $1.11 Million 51.81%

% of portfolio

0.0%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 30, 2025	SELL	$99.29 - $120.52 $490,691 - $595,609	-4,942 Reduced 52.16%	4,532 $534,000
Q1 2025 Apr 28, 2025	BUY	$116.69 - $152.6 $257,534 - $336,788	2,207 Added 30.37%	9,474 $1.11 Million
Q4 2024 Jan 31, 2025	BUY	$125.69 - $146.56 $403,967 - $471,043	3,214 Added 79.3%	7,267 $976,000
Q3 2024 Nov 13, 2024	SELL	$125.42 - $148.48 $4,389 - $5,196	-35 Reduced 0.86%	4,053 $601,000
Q2 2024 Jul 31, 2024	BUY	$129.63 - $154.64 $2,981 - $3,556	23 Added 0.57%	4,088 $529,000
Q1 2024 May 13, 2024	BUY	$128.12 - $149.31 $79,690 - $92,870	622 Added 18.07%	4,065 $591,000
Q4 2023 Feb 09, 2024	BUY	$101.17 - $139.82 $348,328 - $481,400	3,443 New	3,443 $478,000
Q1 2023 Apr 25, 2023	BUY	$131.13 - $159.06 $106,870 - $129,633	815 Added 56.79%	2,250 $311,000
Q4 2022 Feb 03, 2023	BUY	$125.64 - $157.68 $180,293 - $226,270	1,435 New	1,435 $214,000
Q1 2022 May 12, 2022	SELL	$126.0 - $156.48 $189,882 - $235,815	-1,507 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$147.95 - $164.3 $222,960 - $247,600	1,507 New	1,507 $241,000
Q3 2017 Nov 08, 2017	SELL	$58.57 - $66.17 $85,043 - $96,078	-1,452 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	1,452	1,452 $0

Others Institutions Holding A

# of Institutions

1,159

Shares Held

256M

Call Options Held

939K

Put Options Held

652K

View Full List

About AGILENT TECHNOLOGIES, INC.

Ticker A
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 296,040,992
Market Cap $33.5B
Description
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...

More about A

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account